(ANSA) – TOKYO, 13 FEB – The Japanese Ministry of Health aims to bring forward the approval of the coronavirus vaccine developed by the US Pfizer to Sunday, a few days after the arrival of the first supplies, for a total of 400 thousand doses in the country .
This was revealed by sources familiar with the dossier to the Kyodo agency, explaining that the US pharmaceutical company presented the request in Japan last December and initially the green light of the health authorities should have taken place next week.
With an acceleration of administrative procedures, sources said, vaccine administrations could start next Wednesday for about 20 thousand people including doctors and nurses in 100 hospitals.
The Tokyo government has signed agreements with three pharmaceutical companies for the supply of the first 157 million doses, more than enough to cover the approximately 126 million inhabitants of the archipelago. Of these, 72 million will be produced by Pfizer, and the rest by Moderna and AstraZeneca. About 20,000 cold rooms have already been distributed in hospitals for the first vaccine available, that of Pfizer, which has shown efficacy close to 95% in clinical trials conducted globally. (HANDLE).
REPRODUCTION RESERVED © Copyright ANSA